Literature DB >> 1642925

Extradural diamorphine for postoperative analgesia: audit of a nurse-administered service to 800 patients in a district general hospital.

M E Stuart-Taylor1, I S Billingham, R F Barrett, J J Church.   

Abstract

We report the use of extradural diamorphine for postoperative analgesia as a nurse-based service on selected surgical wards in a district general hospital. Eight hundred patients received lumbar or thoracic extradural diamorphine analgesia for postoperative or traumatic pain. Diamorphine was administered in bolus form by suitably trained nursing staff. Satisfactory analgesia, recorded on a verbal rating scale at the conclusion of the service, was achieved in 94.6% of patients. The technique was considered by medical and nursing staff to be a safe and acceptable method of analgesia. Respiratory depression, defined as a ventilatory frequency of less than 10 b.p.m., occurred in seven patients (incidence of 0.9%). All occurred in the theatre recovery area or in the intensive care unit. Retrospectively, each was predictable and all responded to naloxone 0.4 mg.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642925     DOI: 10.1093/bja/68.4.429

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

1.  The safety of concurrent administration of opioids via epidural and intravenous routes for postoperative pain in pediatric oncology patients.

Authors:  Doralina L Anghelescu; Catherine E Ross; Linda L Oakes; Laura L Burgoyne
Journal:  J Pain Symptom Manage       Date:  2008-03-04       Impact factor: 3.612

2.  Intra-operative epidural morphine, fentanyl, and droperidol for control of pain after spinal surgery. A prospective, randomized, placebo-controlled, and double-blind trial.

Authors:  N G Rainov; T Gutjahr; W Burkert
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

3.  [Postoperative pain management on surgical wards-organization of an anaesthesiology-based acute pain service.].

Authors:  H Wulf; C Maier
Journal:  Schmerz       Date:  1994-06       Impact factor: 1.107

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.